trending Market Intelligence /marketintelligence/en/news-insights/trending/oimyryhryiv9evmlnz1zdg2 content esgSubNav
In This List

Mersana adds former Amgen exec to board

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Mersana adds former Amgen exec to board

Cambridge, Mass.-based Mersana Therapeutics Inc. appointed Willard Dere as an independent director of the company.

Dere, who is a professor at the University of Utah Health Sciences Center, has over three decades of research, clinical and regulatory biopharmaceutical leadership experience. He is the former chief medical officer of Amgen and has also served Eli Lilly and Co. in a number of leadership positions, Mersana said in a statement.